NCT04863053View on ClinicalTrials.gov

Thromboxane B2 and Platelet Function Testing as Measures of Aspirin Resistance in Hong Kong Chinese Patients

CompletedOBSERVATIONAL
Enrollment

266

Participants

Timeline

Start Date

April 2, 2015

Primary Completion Date

April 1, 2021

Study Completion Date

April 1, 2021

Conditions
Coronary Disease
Interventions
OTHER

Blood samples will be taken to assess platelet function. There is no change in treatment.

Trial Locations (1)

Unknown

The Chinese University of Hong Kong, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT04863053 - Thromboxane B2 and Platelet Function Testing as Measures of Aspirin Resistance in Hong Kong Chinese Patients | Biotech Hunter | Biotech Hunter